{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T05:22:03Z","timestamp":1785734523878,"version":"3.56.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1904206"],"award-info":[{"award-number":["U1904206"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31870994"],"award-info":[{"award-number":["31870994"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for Central Universities","doi-asserted-by":"publisher","award":["20720180040"],"award-info":[{"award-number":["20720180040"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2018J01055"],"award-info":[{"award-number":["2018J01055"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.biomaterials.2020.119849","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T02:43:41Z","timestamp":1581475421000},"page":"119849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Nanocage encapsulation improves antiepileptic efficiency of phenytoin"],"prefix":"10.1016","volume":"240","author":[{"given":"Jie","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zesen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shefang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhicheng","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biomaterials.2020.119849_bib1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.stem.2014.10.006","article-title":"hPSC-derived maturing GABAergic interneurons ameliorate seizures and abnormal behavior in epileptic mice","volume":"15","author":"Cunningham","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.biomaterials.2020.119849_bib2","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/epi.13655","article-title":"A systematic review of economic evaluations of treatments for patients with epilepsy","volume":"58","author":"Wijnen","year":"2017","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.119849_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrd2997","article-title":"Key factors in the discovery and development of new antiepileptic drugs","volume":"9","author":"Bialer","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2020.119849_bib4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.biomaterials.2016.04.021","article-title":"Pluronic P85-coated poly(butylcyanoacrylate) nanoparticles overcome phenytoin resistance in P-glycoprotein overexpressing rats with lithium-pilocarpine-induced chronic temporal lobe epilepsy","volume":"97","author":"Fang","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2020.119849_bib5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.phrs.2016.03.016","article-title":"The challenges of treating epilepsy with 25 antiepileptic drugs","volume":"107","author":"Santulli","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"21","key":"10.1016\/j.biomaterials.2020.119849_bib6","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1016\/j.biomaterials.2011.03.031","article-title":"Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides","volume":"32","author":"Li","year":"2011","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.biomaterials.2020.119849_bib7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrn1430","article-title":"The neurobiology of antiepileptic drugs","volume":"5","author":"Rogawski","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.119849_bib8","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1365-2230.2006.02185.x","article-title":"Epidemiological study of severe cutaneous adverse drug reactions in a city district of China","volume":"31","author":"Li","year":"2006","journal-title":"Clin. Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.119849_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0920-1211(02)00182-1","article-title":"Overtreatment in epilepsy: adverse consequences and mechanisms","volume":"52","author":"Perucca","year":"2002","journal-title":"Epilepsy Res."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.119849_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1385\/NCC:3:2:161","article-title":"Phenytoin poisoning","volume":"3","author":"Craig","year":"2005","journal-title":"Neurocritical Care"},{"issue":"9","key":"10.1016\/j.biomaterials.2020.119849_bib11","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S1474-4422(12)70153-9","article-title":"Adverse effects of antiepileptic drugs","volume":"11","author":"Perucca","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biomaterials.2020.119849_bib12","doi-asserted-by":"crossref","first-page":"g254","DOI":"10.1136\/bmj.g254","article-title":"Drug treatment of epilepsy in adults","volume":"348","author":"Schmidt","year":"2014","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.biomaterials.2020.119849_bib13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s13311-016-0431-9","article-title":"Electroresponsive nanoparticles improve antiseizure effect of phenytoin in generalized tonic-clonic seizures","volume":"13","author":"Wang","year":"2016","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biomaterials.2020.119849_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biomaterials.2015.09.041","article-title":"Functionalized nanocarrier combined seizure-specific vector with P-glycoprotein modulation property for antiepileptic drug delivery","volume":"74","author":"Liu","year":"2016","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.119849_bib15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/cn400182z","article-title":"Dendrimer advances for the central nervous system delivery of therapeutics","volume":"5","author":"Xu","year":"2014","journal-title":"ACS Chem. Neurosci."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.119849_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrd3499","article-title":"Bio-inspired, bioengineered and biomimetic drug delivery carriers","volume":"10","author":"Yoo","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9\u201310","key":"10.1016\/j.biomaterials.2020.119849_bib17","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/smll.201401952","article-title":"Efficient encapsulation of Fe(3)O(4) nanoparticles into genetically engineered hepatitis B core virus-like particles through a specific interaction for potential bioapplications","volume":"11","author":"Shen","year":"2015","journal-title":"Small"},{"issue":"28","key":"10.1016\/j.biomaterials.2020.119849_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201707567","article-title":"Improved stable indocyanine green (ICG)-Mediated cancer optotheranostics with naturalized hepatitis B core particles","volume":"30","author":"Shan","year":"2018","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.119849_bib19","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.nano.2017.12.002","article-title":"Modularized peptides modified HBc virus-like particles for encapsulation and tumor-targeted delivery of doxorubicin","volume":"14","author":"Shan","year":"2018","journal-title":"Nanomedicine"},{"issue":"20","key":"10.1016\/j.biomaterials.2020.119849_bib20","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1016\/j.biomaterials.2012.03.058","article-title":"Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles","volume":"33","author":"Gao","year":"2012","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.119849_bib21","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.biomaterials.2013.09.063","article-title":"Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer's disease mice","volume":"35","author":"Zhang","year":"2014","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.biomaterials.2020.119849_bib22","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.biomaterials.2012.11.050","article-title":"PEGylated poly(2-(dimethylamino) ethyl methacrylate)\/DNA polyplex micelles decorated with phage-displayed TGN peptide for brain-targeted gene delivery","volume":"34","author":"Qian","year":"2013","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.biomaterials.2020.119849_bib23","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.addr.2012.01.005","article-title":"Virus-based nanocarriers for drug delivery","volume":"64","author":"Ma","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2020.119849_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-3-319-39196-0_5","article-title":"Assembly, engineering and applications of virus-based protein nanoparticles","volume":"940","author":"Mateu","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"issue":"5739","key":"10.1016\/j.biomaterials.2020.119849_bib25","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/282575a0","article-title":"Hepatitis B virus genes and their expression in E. coli","volume":"282","author":"Pasek","year":"1979","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.biomaterials.2020.119849_bib26","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.3415","article-title":"Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture","volume":"12","author":"Pasca","year":"2015","journal-title":"Nat. Methods"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.119849_bib27","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.yebeh.2009.05.013","article-title":"Positive impact of omega-3 fatty acid supplementation in a dog with drug-resistant epilepsy: a case study","volume":"15","author":"Scorza","year":"2009","journal-title":"Epilepsy Behav."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.119849_bib28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.physbeh.2009.09.005","article-title":"A revised Racine's scale for PTZ-induced seizures in rats","volume":"98","author":"Luttjohann","year":"2009","journal-title":"Physiol. Behav."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.119849_bib29","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s11671-016-1554-y","article-title":"Construction and immunological evaluation of CpG-Au@HBc virus-like nanoparticles as a potential vaccine","volume":"11","author":"Wang","year":"2016","journal-title":"Nanoscale Res. Lett."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.119849_bib30","doi-asserted-by":"crossref","first-page":"696","DOI":"10.7150\/ijms.24257","article-title":"Low-dose Evans blue dye for near-infrared fluorescence imaging in photothrombotic stroke model","volume":"15","author":"Ryu","year":"2018","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.119849_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11060-010-0466-4","article-title":"Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy","volume":"104","author":"Joshi","year":"2011","journal-title":"J. Neuro Oncol."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.119849_bib32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1179\/016164102101199611","article-title":"Spontaneous recurrent seizures and neuropathology in the chronic phase of the pilocarpine and picrotoxin model epilepsy","volume":"24","author":"Hamani","year":"2002","journal-title":"Neurol. Res."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.119849_bib33","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1528-1167.2007.00980.x","article-title":"Resistance to phenobarbital extends to phenytoin in a rat model of temporal lobe epilepsy","volume":"48","author":"Bethmann","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.biomaterials.2020.119849_bib34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.biomaterials.2016.04.021","article-title":"Pluronic P85-coated poly(butylcyanoacrylate) nanoparticles overcome phenytoin resistance in P-glycoprotein overexpressing rats with lithium-pilocarpine-induced chronic temporal lobe epilepsy","volume":"97","author":"Fang","year":"2016","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.biomaterials.2020.119849_bib35","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nmeth.4304","article-title":"Fused cerebral organoids model interactions between brain regions","volume":"14","author":"Bagley","year":"2017","journal-title":"Nat. Methods"},{"issue":"7467","key":"10.1016\/j.biomaterials.2020.119849_bib36","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biomaterials.2020.119849_bib37","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.cell.2016.04.032","article-title":"Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure","volume":"165","author":"Qian","year":"2016","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.119849_bib38","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1021\/acs.molpharmaceut.6b00770","article-title":"P-gp protein expression and transport activity in rodent seizure models and human epilepsy","volume":"14","author":"Hartz","year":"2017","journal-title":"Mol. Pharm."},{"issue":"12","key":"10.1016\/j.biomaterials.2020.119849_bib39","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nm.3407","article-title":"Development, maintenance and disruption of the blood-brain barrier","volume":"19","author":"Obermeier","year":"2013","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.119849_bib40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0378-5173(99)00129-5","article-title":"Buffer capacity and precipitation control of pH solubilized phenytoin formulations","volume":"185","author":"Alvarez-Nunez","year":"1999","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.119849_bib41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/00003088-199018020-00004","article-title":"Pharmacokinetic drug interactions with phenytoin (Part II)","volume":"18","author":"Nation","year":"1990","journal-title":"Clin. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.119849_bib42","first-page":"276","article-title":"Paradoxical seizures in phenytoin toxicity","volume":"40","author":"Chua","year":"1999","journal-title":"Singap. Med. J."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.119849_bib43","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.addr.2011.10.007","article-title":"Nanotechnological advances for the delivery of CNS therapeutics","volume":"64","author":"Wong","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.119849_bib44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40580-018-0168-8","article-title":"Therapeutic nanoplatforms and delivery strategies for neurological disorders","volume":"5","author":"Kang","year":"2018","journal-title":"Nano Converg."},{"key":"10.1016\/j.biomaterials.2020.119849_bib45","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.2147\/IJN.S149022","article-title":"Theranostic applications of nanoparticles in neurodegenerative disorders","volume":"13","author":"Ramanathan","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"6146","key":"10.1016\/j.biomaterials.2020.119849_bib46","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/330381a0","article-title":"Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein","volume":"330","author":"Clarke","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2020.119849_bib47","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.biomaterials.2016.12.012","article-title":"Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo","volume":"120","author":"Mohamed Suffian","year":"2017","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biomaterials.2020.119849_bib48","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1021\/acs.nanolett.8b04722","article-title":"Bioengineered nanocage from HBc protein for combination cancer immunotherapy","volume":"19","author":"Shan","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2020.119849_bib49","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3389\/fchem.2018.00620","article-title":"Biomedical applications of metallosupramolecular assemblies-structural aspects of the anticancer activity","volume":"6","author":"Ahmedova","year":"2018","journal-title":"Front Chem."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.119849_bib50","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1039\/C8NR04916E","article-title":"Nanoparticle heterogeneity: an emerging structural parameter influencing particle fate in biological media?","volume":"11","author":"Rabanel","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.biomaterials.2020.119849_bib51","article-title":"Charged metal nanoparticles for chemoelectronic circuits","author":"Zhao","year":"2019","journal-title":"Adv. Mater."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961220300958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961220300958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:50:13Z","timestamp":1758905413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961220300958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":51,"alternative-id":["S0142961220300958"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2020.119849","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanocage encapsulation improves antiepileptic efficiency of phenytoin","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2020.119849","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119849"}}